Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy

Area of Science:

• Oncology
• Molecular Biology
• Virology

Background:

• Extracellular matrix remodeling during chronic inflammation impacts cancer progression.
• Matrix metalloproteinases (MMPs), particularly MMP3, play crucial roles in tumor growth and metastasis.
• Previous attempts targeting MMPs in cancer therapy have faced challenges with efficacy and toxicity.

Purpose of the Study:

• To investigate the potential of targeting matrix metalloproteinase-3 (MMP3) in combination with oncolytic viruses for cancer therapy.
• To evaluate the efficacy of MMP3 inhibitors alone and in combination with oncolytic viruses.
• To elucidate the underlying mechanisms of MMP3 in cancer progression.

Main Methods:

• Analysis of MMP3 expression in various cancer types.
• Preclinical studies using colon cancer models treated with MMP3 inhibitors and/or oncolytic viruses.
• Investigation of signaling pathways (Erk1/2, NF-κB) involved in MMP3-mediated tumor cell behavior.

Main Results:

• MMP3 expression was upregulated in multiple cancers and found to be critical for tumor growth and metastasis.
• Single-agent MMP3 inhibition was ineffective in preclinical colon cancer models.
• Combination therapy of MMP3 inhibitors with an oncolytic virus demonstrated significantly enhanced therapeutic effects.

Conclusions:

• MMP3 is a viable therapeutic target in cancer.
• Combining MMP3 inhibition with oncolytic virus therapy represents a promising strategy for improving cancer treatment outcomes.
• MMP3 influences tumor cell proliferation and invasion through Erk1/2 and NF-κB signaling pathways.